A detailed history of Clarity Asset Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Clarity Asset Management, Inc. holds 405 shares of ABT stock, worth $47,692. This represents 0.03% of its overall portfolio holdings.

Number of Shares
405
Previous 403 0.5%
Holding current value
$47,692
Previous $41.9 Million 10.28%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $200 - $236
2 Added 0.5%
405 $46.2 Million
Q2 2024

Aug 15, 2024

BUY
$100.73 - $112.44 $6,446 - $7,196
64 Added 18.88%
403 $41.9 Million
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $4,928 - $5,443
-45 Reduced 11.72%
339 $38.5 Million
Q4 2023

Feb 15, 2024

BUY
$90.19 - $110.4 $34,632 - $42,393
384 New
384 $42.3 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Clarity Asset Management, Inc. Portfolio

Follow Clarity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clarity Asset Management, Inc. with notifications on news.